In small case series of people with PBH, treatment with the GLP-1 analogue liraglutide improved symptoms of hypoglycaemia, fasting and post-prandial glucose concentrations, lowered insulin levels during an OGTT and in one case reduced time in hypoglycaemia on CGM. The gene discussed is GLP1R; the disease is Hypoglycemia.